Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Dynogen Pharmaceuticals Inc.

Latest From Asubio Pharma Co. Ltd.

Daiichi Sankyo Hoping Its Post-Olmesartan Plan Comes Together

"I love it when a plan comes together," Hannibal Smith of TV show The A-Team used to say, a catchphrase which Daiichi Sankyo will be hoping is appropriate in around five years' time as it looks back on the results of its new mid-term strategy.

BioPharmaceutical Japan

Daiichi Sankyo New R&D Head Puts Emphasis On Faster Decision-making

Daiichi Sankyo has four large Phase III milestones in the next two years, followed by prioritization for early stage programs

BioPharmaceutical Japan
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Gastrointestinal
  • Gynecological, Urological
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Dynogen Pharmaceuticals Inc.
  • Senior Management
  • Lee R Brettman, MD, Pres. & CEO
    Robert C Lorette, SVP, CBO
    Spellman W Michael, PhD, SVP, Pharmaceutical Dev.
    Scott Holmes, VP, Fin. & Admin.
  • Contact Info
  • Dynogen Pharmaceuticals Inc.
    Phone: (781) 839-5100
    52 Second St.
    Waltham, MA 02451